Burning Rock Biotech (BNR) Asset Utilization Ratio (2020 - 2026)

Burning Rock Biotech's Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.63 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 5.36% year-over-year to 0.63; the TTM figure through Mar 2026 stood at 0.63 (up 5.36% YoY), while the FY2025 annual figure was 0.65, up 22.53% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.63, down from 0.66 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.66 in Q4 2025, with the low at 0.24 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.51 (2024), against an average of 0.48.
• The sharpest annual moves came in 2022 and 2026: Asset Utilization Ratio jumped 67.07% in 2022, then grew 5.36% in 2026.
• Burning Rock Biotech's Asset Utilization Ratio stood at 0.36 in 2022, then jumped by 38.93% to 0.5 in 2023, then advanced by 9.63% to 0.54 in 2024, then increased by 21.1% to 0.66 in 2025, then fell by 3.61% to 0.63 in 2026.
• Business Quant data shows BNR's Asset Utilization Ratio at 0.63 in Q1 2026, 0.66 in Q4 2025, and 0.65 in Q3 2025.